Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis--insights into possible drug mechanism

Eur J Clin Pharmacol. 2014 Mar;70(3):373-5. doi: 10.1007/s00228-013-1620-7. Epub 2013 Dec 6.

Authors

Victor Voon¹, Lavanya Saiva, Sara O'Kelly, David Keane

Affiliation

¹ St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland, [email protected].

PMID: 24309839
DOI: 10.1007/s00228-013-1620-7

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Atrioventricular Block / chemically induced*
Atrioventricular Block / physiopathology
Female
Fingolimod Hydrochloride
Humans
Immunosuppressive Agents / adverse effects*
Immunosuppressive Agents / therapeutic use
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Propylene Glycols / adverse effects*
Propylene Glycols / therapeutic use
Sphingosine / adverse effects
Sphingosine / analogs & derivatives*
Sphingosine / therapeutic use
Young Adult

Substances

Immunosuppressive Agents
Propylene Glycols
Fingolimod Hydrochloride
Sphingosine